У амеров кроме кнопки SELL ничего нет.

минимум 5 жду

@antidot21 😂😂😂

(NASDAQ:ZYNE) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.25) by 4 percent. This is a 16.13 percent increase over losses of $(0.31) per share Benzinga·11/15/2021, 3:25:33 PM Disclaimer: This article represents only the author's personal opinion and does not constitute ... Unfold Listen to the news Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.25) by 4 percent. This is a 16.13 percent increase over losses of $(0.31) per share from the same period last year.

Сначала опустят до 4.1, потом поднимут до 4.5